Five-year follow-up of a case of lipoprotein glomerulopathy with APOE Kyoto mutation

CEN Case Reports
Ryosuke UsuiMinako Koike

Abstract

We report the case of a 34-year-old Japanese male with lipoprotein glomerulopathy (LPG). Renal biopsy showed LPG, and followed by a genetic analysis revealed a mutation in apolipoprotein E gene (APOE Kyoto; Arg25Cys). We started treatment with probucol, bezafibrate, losartan, and allopurinol. Urinary protein decreased in response to treatment but has remained at about 1.27 ± 0.71 g/gCr, and a repeat biopsy which was performed 1 year after the first biopsy showed no clear evidence of pathological remission and complication of other glomerular disease. After 5 years of follow-up after the start of treatment, renal function has almost maintained without apparent deterioration. Interestingly, the course of the urinary protein level closely paralleled his triglyceride and cholesterol levels in a long-term. This observation suggests the importance of tight control of lipid profiles as a means of renoprotection in LPG patient.

References

Feb 1, 1989·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·T SaitoH Sakaguchi
Apr 4, 1986·Science·M S Brown, J L Goldstein
Dec 12, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P A AndrewsM Bewick
Feb 24, 2001·Pediatrics International : Official Journal of the Japan Pediatric Society·M ShimizuM Nozawa
Jun 1, 2002·Journal of the American Society of Nephrology : JASN·Yutaka KanamaruChisei Ra
Dec 25, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Norio IeiriYoshio Taguma
Jan 25, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Takao SaitoShinichi Oikawa
May 5, 2006·Kidney International·C W ParkY Guan
Nov 30, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Masaru KinomuraHirofumi Makino
Oct 9, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Zhang XinLi Leishi
Nov 28, 2008·American Journal of Physiology. Renal Physiology·Keiichi KonoToshifumi Aoyama
May 22, 2009·Clinical and Experimental Nephrology·Atsunori IshimuraTakao Saito
Jul 16, 2009·Clinical and Experimental Nephrology·Akira MatsunagaKiyoshi Hayasaka
Sep 16, 2010·Clinical and Experimental Nephrology·Hiroko HamataniYoshihisa Nojima
Apr 7, 2011·Journal of Atherosclerosis and Thrombosis·Takehiko TokuraNaoki Kashihara
Aug 7, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Kenji ItoTakao Saito
Aug 10, 2012·Clinical Nephrology·Min-Tser LiaoYong-Kwei Tsau
Feb 15, 2013·Journal of Human Genetics·Kentaro ToyotaKiyoshi Hayasaka

❮ Previous
Next ❯

Citations

Nov 14, 2018·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·Eduardo Cambruzzi, Karla Lais Pêgas

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.